Evidence map›Paper›PMID 39189664›Full record

ArticleThe Biochemical journal2024

Filamin A regulates platelet shape change and contractile force generation via phosphorylation of the myosin light chain.

Felix Hong, Molly Y Mollica, Kalyan Golla, Enoli De Silva, Nathan J Sniadecki, José A López, Hugh Kim

Abstract read
In one paragraph

Article in The Biochemical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Felix HongCentre for Blood Research, University of British Columbia, Vancouver, BC, Canada.
Molly Y MollicaBloodworks Northwest Research Institute, Seattle, WA, U.S.A.
Kalyan GollaCentre for Blood Research, University of British Columbia, Vancouver, BC, Canada.
Enoli De SilvaCentre for Blood Research, University of British Columbia, Vancouver, BC, Canada.
Nathan J SniadeckiDepartment of Mechanical Engineering, University of Washington, Seattle, WA, U.S.A.
José A LópezBloodworks Northwest Research Institute, Seattle, WA, U.S.A.
Hugh KimCentre for Blood Research, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-1543-6726

Funding

RESEARCH TRAINING IN HEMATOLOGYT32HL007093 · NHLBI · UNIVERSITY OF WASHINGTON · PI Janis L Abkowitz · 1985 to 2026
$13.9M
UW Center for Translational Muscle Research (Overall Application)P30AR074990 · NIAMS · UNIVERSITY OF WASHINGTON · PI Jennifer Michelle Davis, DANIEL RAFTERY · 2019 to 2026
$7.5M
Molecular and Translational Studies in Hematologic DisordersR35HL145262 · NHLBI · BLOODWORKS · PI LOPEZ, JOSE ARON · 2019 to 2024
$6.5M
Mechanotransduction by Melusin in Cardiac HypertrophyR01HL149734 · NHLBI · UNIVERSITY OF WASHINGTON · PI SNIADECKI, NATHAN JOHN · 2020 to 2023
$2.1M
NHLBI NIH HHS R01 HL149734NHLBI NIH HHS R35 HL145262NHLBI NIH HHS T32 HL007093NIAMS NIH HHS P30 AR074990
6 · The paper itself

Abstract

Platelets are critical mediators of hemostasis and thrombosis. Platelets circulate as discs in their resting form but change shape rapidly upon activation by vascular damage and/or soluble agonists such as thrombin. Platelet shape change is driven by a dynamic remodeling of the actin cytoskeleton. Actin filaments interact with the protein myosin, which is phosphorylated on the myosin light chain (MLC) upon platelet activation. Actin-myosin interactions trigger contraction of the actin cytoskeleton, which drives platelet spreading and contractile force generation. Filamin A (FLNA) is an actin cross-linking protein that stabilizes the attachment between subcortical actin filaments and the cell membrane. In addition, FLNA binds multiple proteins and serves as a critical intracellular signaling scaffold. Here, we used platelets from mice with a megakaryocyte/platelet-specific deletion of FLNA to investigate the role of FLNA in regulating platelet shape change. Relative to controls, FLNA-null platelets exhibited defects in stress fiber formation, contractile force generation, and MLC phosphorylation in response to thrombin stimulation. Blockade of Rho kinase (ROCK) and protein kinase C (PKC) with the inhibitors Y27632 and bisindolylmaleimide (BIM), respectively, also attenuated MLC phosphorylation; our data further indicate that ROCK and PKC promote MLC phosphorylation through independent pathways. Notably, the activity of both ROCK and PKC was diminished in the FLNA-deficient platelets. We conclude that FLNA regulates thrombin-induced MLC phosphorylation and platelet contraction, in a ROCK- and PKC-dependent manner.

Indexed as

Blood PlateletsFilaminsMyosin Light ChainsAnimalsCell ShapeMiceMice, KnockoutPhosphorylationProtein Kinase Crho-Associated KinasesThrombinFilaminsFlnA protein, mouseMyosin Light ChainsProtein Kinase Crho-Associated KinasesThrombincytoskeletonFilamin Amyosinphosphorylationplateletsprotease-activated receptor signaling

Identifiers

PMID39189664
PMCPMC11555712

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.